NCT01179854

Remegal Different Doses in Patients With Refractory Partial Seizures

Phase 2 Double-blind,Placebo-controlled Study for Evaluation of Efficiency, Safety,Tolerance and Pharmacokinetics of Different Doses of Remegal in Additional Therapy for Patients With Refractory Partial Seizures

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Valexfarm · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine weather different doses of Remegal are effective,safety and tolerant in Additional Therapy for Patients With Refractory Partial Seizures and pharmacokinetics definition

Detailed description

Phase II

Conditions

• Drug Safety
• Normal Drug Tolerance
• Self Efficacy

Interventions

Type	Name	Description
DRUG	Remegal	Drug/ placebo

Timeline

• Start date: 2009-09-01
• Primary completion: 2010-11-01
• Completion: 2011-09-01
• First posted: 2010-08-11
• Last updated: 2017-05-11

Locations

4 sites across 1 country: Russia